|
Market Closed -
NSE India S.E.
19:05:08 21/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,317.90 INR | -0.64% |
|
-0.02% | +13.89% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 654B 6.84B 5.86B 5.48B 5.02B 9.41B 9.54B 64.74B 25.25B 329B 25.67B 25.11B 1,087B | P/E 2027 * |
28.2x | P/E 2028 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 618B 6.46B 5.53B 5.17B 4.74B 8.89B 9.01B 61.13B 23.84B 310B 24.24B 23.71B 1,026B | EV / Sales 2027 * |
3.68x | EV / Sales 2028 * | 3.24x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.64% | ||
| 1 week | -0.02% | ||
| Current month | +3.76% | ||
| 1 month | +3.38% | ||
| 3 months | -3.14% | ||
| 6 months | +13.44% | ||
| Current year | +13.89% |
| 1 week | 2,222.5 |  | 2,348.6 |
| 1 month | 2,162 | | 2,348.6 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | -0.02% | +19.42% | +199.06% | 6.84B | |
| -0.08% | -1.43% | +15.99% | +67.26% | 47.71B | |
| -3.21% | +1.37% | +52.36% | +125.75% | 40.3B | |
| -0.40% | -1.23% | -10.08% | +16.08% | 12.09B | |
| +1.11% | -1.34% | +13.61% | +71.49% | 11.68B | |
| 0.00% | +0.58% | +30.65% | +148.80% | 9.19B | |
| -0.39% | -0.92% | +19.81% | +39.54% | 7.57B | |
| -1.35% | +0.74% | +47.03% | -11.93% | 7.24B | |
| -5.36% | -6.36% | -36.28% | +18.28% | 5.42B | |
| -0.51% | -0.90% | +37.01% | +103.41% | 4.75B | |
| Average | -1.08% | -1.09% | +18.95% | +77.78% | 15.28B | |
| Weighted average by Cap. | -1.14% | -0.58% | +24.83% | +84.03% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.76B 1.5B 1.41B 1.29B 2.42B 2.45B 16.62B 6.48B 84.36B 6.59B 6.45B 279B | 187B 1.96B 1.68B 1.57B 1.43B 2.69B 2.73B 18.52B 7.22B 94B 7.34B 7.18B 311B |
| Net income | 23.11B 242M 207M 194M 177M 333M 337M 2.29B 892M 11.61B 907M 887M 38.4B | 27.71B 290M 248M 232M 212M 399M 404M 2.74B 1.07B 13.92B 1.09B 1.06B 46.04B |
| Net Debt | -36.49B -381M -327M -306M -280M -525M -532M -3.61B -1.41B -18.33B -1.43B -1.4B -60.63B | -48B -502M -430M -402M -368M -691M -700M -4.75B -1.85B -24.11B -1.88B -1.84B -79.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | ₹2,317.90 | -0.64% | 237,421 |
| 20/08/26 | ₹2,332.90 | +3.85% | 552,157 |
| 19/08/26 | ₹2,246.50 | -2.54% | 833,583 |
| 18/08/26 | ₹2,305.00 | -1.03% | 379,551 |
| 17/08/26 | ₹2,329.00 | +0.46% | 305,189 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
